0001448431
2019-01-01
2019-09-30
0001448431
srt:DirectorMember
2019-01-01
2019-03-31
0001448431
srt:DirectorMember
2018-01-01
2018-03-31
0001448431
us-gaap:StockOptionMember
2019-01-01
2019-03-31
0001448431
us-gaap:RestrictedStockMember
2019-01-01
2019-03-31
0001448431
us-gaap:CommonStockMember
2018-01-01
2018-03-31
0001448431
2019-09-30
0001448431
2018-12-31
0001448431
2019-01-02
0001448431
2018-01-01
2018-09-30
0001448431
2017-12-31
0001448431
2018-06-30
0001448431
us-gaap:CommonStockMember
2017-12-31
0001448431
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0001448431
us-gaap:RetainedEarningsMember
2017-12-31
0001448431
us-gaap:CommonStockMember
2018-12-31
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0001448431
us-gaap:RetainedEarningsMember
2018-12-31
0001448431
us-gaap:CommonStockMember
2018-03-31
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-03-31
0001448431
us-gaap:RetainedEarningsMember
2018-03-31
0001448431
us-gaap:CommonStockMember
2019-03-31
0001448431
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0001448431
us-gaap:RetainedEarningsMember
2019-03-31
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-01-01
2018-03-31
0001448431
us-gaap:RetainedEarningsMember
2018-01-01
2018-03-31
0001448431
us-gaap:CommonStockMember
2019-01-01
2019-03-31
0001448431
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-31
0001448431
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-31
0001448431
2018-12-25
2019-01-02
0001448431
2019-07-01
2019-09-30
0001448431
oprx:NewJerseyMember
srt:MinimumMember
2019-01-01
2019-09-30
0001448431
oprx:NewJerseyMember
srt:MaximumMember
2019-01-01
2019-09-30
0001448431
oprx:MichiganMember
srt:MinimumMember
2019-01-01
2019-09-30
0001448431
oprx:MichiganMember
srt:MaximumMember
2019-01-01
2019-09-30
0001448431
oprx:MichiganMember
2019-01-01
2019-09-30
0001448431
oprx:NewJerseyMember
2019-01-01
2019-09-30
0001448431
us-gaap:PrivatePlacementMember
2018-04-01
2018-06-30
0001448431
2018-07-01
2018-09-30
0001448431
oprx:UnderwriterMember
2019-04-01
2019-06-30
0001448431
us-gaap:StockOptionMember
2019-07-01
2019-09-30
0001448431
us-gaap:StockOptionMember
2018-07-01
2018-09-30
0001448431
srt:DirectorMember
2019-07-01
2019-09-30
0001448431
2018-01-01
2018-03-31
0001448431
srt:DirectorMember
2018-07-01
2018-09-30
0001448431
2018-05-01
2018-05-14
0001448431
2018-05-14
0001448431
us-gaap:CommonStockMember
2019-07-01
2019-09-30
0001448431
us-gaap:CommonStockMember
2018-07-01
2018-09-30
0001448431
us-gaap:CommonStockMember
2019-09-30
0001448431
us-gaap:CommonStockMember
2018-06-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2019-07-01
2019-09-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-07-01
2018-09-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2019-09-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-06-30
0001448431
us-gaap:RetainedEarningsMember
2019-07-01
2019-09-30
0001448431
us-gaap:RetainedEarningsMember
2018-07-01
2018-09-30
0001448431
us-gaap:RetainedEarningsMember
2019-09-30
0001448431
us-gaap:RetainedEarningsMember
2018-06-30
0001448431
2019-03-31
0001448431
2018-03-31
0001448431
2019-01-01
2019-03-31
0001448431
oprx:WPPPLCMember
2018-01-01
2018-03-31
0001448431
us-gaap:StockOptionMember
2019-04-01
2019-06-30
0001448431
us-gaap:StockOptionMember
2018-04-01
2018-06-30
0001448431
srt:DirectorMember
2019-04-01
2019-06-30
0001448431
srt:DirectorMember
2018-04-01
2018-06-30
0001448431
oprx:InvestorRelationsServicesMember
2018-07-01
2018-09-30
0001448431
us-gaap:SubsequentEventMember
2019-10-01
2019-10-31
0001448431
2019-10-31
0001448431
2019-10-01
2019-10-31
0001448431
2019-11-30
0001448431
us-gaap:SubsequentEventMember
2019-10-02
2019-10-30
0001448431
2019-11-01
0001448431
us-gaap:CommonStockMember
2018-04-01
2018-06-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-04-01
2018-06-30
0001448431
us-gaap:RetainedEarningsMember
2018-04-01
2018-06-30
0001448431
2018-04-01
2018-06-30
0001448431
us-gaap:CommonStockMember
2018-09-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2018-09-30
0001448431
us-gaap:RetainedEarningsMember
2018-09-30
0001448431
2018-09-30
0001448431
us-gaap:CommonStockMember
2019-04-01
2019-06-30
0001448431
us-gaap:CommonStockMember
2019-06-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2019-04-01
2019-06-30
0001448431
us-gaap:AdditionalPaidInCapitalMember
2019-06-30
0001448431
us-gaap:RetainedEarningsMember
2019-04-01
2019-06-30
0001448431
us-gaap:RetainedEarningsMember
2019-06-30
0001448431
2019-04-01
2019-06-30
0001448431
2019-06-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
100000
2084
12052
29759967
8914034
5122573
13523002
7158390
6457841
973177
360146
37891534
15732021
156809
149330
3678513
3678513
2604677
2766944
3542462
2492123
92239
235647
10505388
9173227
48553731
25054578
1095474
411010
607000
1300882
1668287
1908616
113476
810000
1115904
610625
5410141
4231133
478201
1530000
2365000
2008201
2365000
7418342
6596133
14174
12039
72561045
48725211
-31439830
-30278805
41135389
18458445
6220539
15800058
9773
36573888
-30363122
12039
48725211
-30278805
9879
37517904
-30694328
12279
49705102
-30275505
14174
11557
72561045
46202320
-31439830
-30413819
19441876
6833455
11971
47361086
-30168891
17204366
14117
71764534
-29868888
41909763
48553731
25054578
14173850
12038618
382893
17218492
14627094
5002767
5415384
6251766
6513810
1981143
2268968
10966726
8113284
3021624
3146416
12341827
7807705
5008934
2923238
-1375101
305579
-1987310
223178
192305
30679
136368
21750
-1157796
336258
-1570942
244928
OptimizeRx Corp
0001448431
false
--12-31
10-Q
2019-09-30
Q3
2019
Accelerated Filer
false
true
false
14173850
25000
280000
94105
465000
79071
2707
2808
6384
6688
P3Y
Yes
false
001-38543
Yes
NV
2022-11-30
2022-12-31
587497
462000
8336
6249
89826
130001
1666669
1769275
48775
141403
8336
11489
100000
60295
2002
8336
8336
10000
1666669
1769275
106034
28875
343785
206324
451022
120705
206082
214314
4920
135043
89945
148050
1667
8162807
8164474
1769
21302057
21303826
9000000
23000575
8164474
21303826
835526
1696749
We implemented a reverse split of our common stock by exchanging each three shares of our common stock for one share.
908
140000
78225
364008
217305
30679
416368
21750
1329713
878768
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 1 – NATURE OF BUSINESS AND BASIS
OF PRESENTATION</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying condensed consolidated financial statements
include OptimizeRx Corporation and its wholly owned subsidiaries (collectively, the "Company", "we", "our",
or "us").</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a leading provider of digital health messaging via electronic
health records (EHRs), providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients.
Our cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior
authorization, education and critical clinical information. Our network is comprised of leading EHR platforms and provides more
than half a million healthcare providers access to these services within their workflow at the point of care.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The condensed consolidated financial statements for the three
and nine months ended September 30, 2019 and 2018 are unaudited and have been prepared pursuant to the rules and regulations of
the U.S. Securities and Exchange Commission ("SEC"). In the opinion of management, all adjustments necessary to present
fairly our consolidated financial position as of September 30, 2019, and our results of operations and changes in stockholders'
equity for the three and nine months ended September 30, 2019 and 2018 and the statements of cash flows for the nine months ended
September 30, 2019 and 2018 have been made. Those adjustments consist of normal and recurring adjustments. The condensed consolidated
balance sheet as of December 31, 2018 has been derived from the audited consolidated balance sheet as of that date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain information and note disclosures, including a detailed
discussion about the Company's significant accounting policies, normally included in our annual financial statements prepared
in accordance with generally accepted accounting principles ("GAAP") have been condensed or omitted. These consolidated
condensed financial statements should be read in conjunction with a reading of the financial statements and notes thereto included
in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, as filed with the U.S. Securities and Exchange Commission
on March 12, 2019.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The results of operations for the three and nine months ended
September 30, 2019 are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have
been made in the prior period's condensed consolidated financial statements to conform to the current period's presentation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 2 – NEW ACCOUNTING STANDARDS</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In February 2016, the Financial Accounting Standards Board ("FASB")
issued new accounting guidance on leases. The accounting standard, effective January 1, 2019, requires virtually all leases to
be recognized on the balance sheet. Effective January 1, 2019, we adopted the standard using the modified retrospective method,
under which we elected the package of practical expedients and transition provisions allowing us to bring our existing operating
leases onto the consolidated balance sheet without adjusting comparative periods, but recognizing a cumulative-effect adjustment
to the opening balance of accumulated deficit on January 1, 2019. Under the guidance, we have also elected not to separate lease
and non-lease components in recognition of the lease-related assets and liabilities, as well as the related lease expense.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have operating leases with terms greater than 12 months for
office space in three multitenant facilities, which are recorded as assets and liabilities. The lease on our headquarters space
in Rochester, Michigan expires November 30, 2022, with a three-year renewal option through 2025, with monthly rent payable at rates
ranging from $6,384 to $6,688. We have assumed renewal of the lease. We also have a lease on office space in Cranbury, New Jersey,
expiring in 2022 with monthly payments ranging from $2,707 to $2,808, as well as a lease of approximately $1,800 per month in Zagreb,
Croatia expiring in 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lease-related assets, or right-of-use assets, are recognized
at the lease commencement date at amounts equal to the respective lease liabilities, adjusted for prepaid lease payments, initial
direct costs, and lease incentives received. Lease-related liabilities are recognized at the present value of the remaining contractual
fixed lease payments, discounted using our incremental borrowing rate. Operating lease expense is recognized on a straight-line
basis over the lease term, while variable lease payments are expensed as incurred. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon adoption of the standard on January 1, 2019, we recorded
approximately $462,000 of right of use assets and $465,000 of lease-related liabilities, with the difference recorded in accumulated
deficit as the cumulative effect of change in accounting principle at that date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three and nine months ended September 30, 2019, the
Company's lease cost consisted of the following components, each of which is included in operating expenses within the Company's
consolidated statements of operations:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 11pt"> </p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br /> September 30, <br /> 2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br /> September 30,<br /> 2019</td><td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td> </td>
<td colspan="2"> </td><td> </td><td> </td>
<td colspan="2"> </td><td> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 76%; text-align: left">Operating lease cost</td><td style="width: 1%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,868</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">98,043</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1.5pt">Short-term lease cost (1)</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,771</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,663</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 4pt">Total lease cost</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">45,639</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">128,706</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Short-term lease cost includes any lease with a term
of less than 12 months.</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below presents the future minimum lease payments to
be made under operating leases as of September 30, 2019:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
<td style="text-align: left">For the year ending December 31,</td><td> </td>
<td colspan="2"> </td><td> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 88%; text-align: left; text-indent: -12pt; padding-left: 12pt">2019(a)</td><td style="width: 1%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,977</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2020</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">138,019</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2021</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">140,367</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2022</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">102,367</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2023</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">99,209</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt; text-align: left">Thereafter</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">150,599</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -12pt; padding-left: 12pt; text-align: left">Total</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">664,538</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt">Less: present value discount</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,861</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 4pt; text-indent: -12pt; padding-left: 12pt">Total lease liabilities</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">591,677</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">For the remaining three-month period beginning October
1, 2019.</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The weighted average remaining lease term for operating leases
is 5.2 years and the weighted average discount rate used in calculating the operating lease asset and liability is 4.5%. Cash paid
for amounts included in the measurement of lease liabilities is $94,105. For the nine months ended September 30, 2019, payments
on lease obligations were $79,071 and amortization on the right of use assets was $80,022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Accounting Pronouncements</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2016, the FASB issued Accounting Standards Update ("ASU")
2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 provides
for a new impairment model, which requires measurement and recognition of expected credit losses for most financial assets and
certain other instruments, including but not limited to accounts receivable and available for sale debt securities. ASU 2016-13
will become effective for the Company on January 1, 2020 and early adoption is permitted. The Company is currently evaluating the
impact of this guidance on its consolidated financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill
and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the subsequent measurement of goodwill
by eliminating the second step of the goodwill impairment test. The second step measures a goodwill impairment loss by comparing
the implied fair value of a reporting unit's goodwill with the carrying amount of that goodwill. Under ASU 2017-04, a company
will record an impairment charge based on the excess of a reporting unit's carrying amount over its fair value. ASU 2017-04
will be applied prospectively and is effective for annual or interim goodwill impairment tests in fiscal years beginning after
December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after
January 1, 2017. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement
(Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure
requirements on fair value measurements and will become effective for the Company on January 1, 2020 and early adoption is permitted.
The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 11pt"></p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br /> September 30, <br /> 2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br /> September 30,<br /> 2019</td><td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td> </td>
<td colspan="2"> </td><td> </td><td> </td>
<td colspan="2"> </td><td> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 76%; text-align: left">Operating lease cost</td><td style="width: 1%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,868</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">98,043</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1.5pt">Short-term lease cost (1)</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,771</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,663</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 4pt">Total lease cost</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">45,639</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">128,706</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Short-term lease cost includes any lease with a term
of less than 12 months.</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
<td style="text-align: left">For the year ending December 31,</td><td> </td>
<td colspan="2"> </td><td> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 88%; text-align: left; text-indent: -12pt; padding-left: 12pt">2019(a)</td><td style="width: 1%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,977</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2020</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">138,019</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2021</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">140,367</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2022</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">102,367</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -12pt; padding-left: 12pt">2023</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">99,209</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt; text-align: left">Thereafter</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">150,599</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -12pt; padding-left: 12pt; text-align: left">Total</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">664,538</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt">Less: present value discount</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,861</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 4pt; text-indent: -12pt; padding-left: 12pt">Total lease liabilities</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">591,677</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">For the remaining three-month period beginning October
1, 2019.</td></tr></table>
98043
33868
128706
45639
138019
140367
102367
99209
150599
664538
72861
591677
We have operating leases with terms greater than 12 months for office space in three multitenant facilities, which are recorded as assets and liabilities. The lease on our headquarters space in Rochester, Michigan expires November 30, 2022, with a three-year renewal option through 2025, with monthly rent payable at rates ranging from $6,384 to $6,688. We have assumed renewal of the lease. We also have a lease on office space in Cranbury, New Jersey, expiring in 2022 with monthly payments ranging from $2,707 to $2,808, as well as a lease of approximately $1,800 per month in Zagreb, Croatia expiring in 2022.
P5Y2M12D
80022
0.045
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 3 – STOCKHOLDERS' EQUITY</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the quarter ended June 30, 2019, in an underwritten primary
offering, we issued 1,769,275 shares of our common stock for gross proceeds of $23,000,575. In connection with this transaction,
we incurred equity issuance costs of $1,696,749 related to payments to the underwriter, advisors and legal fees associated with
the transaction, resulting in net proceeds to the Company of $21,303,826.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the quarter ended June 30, 2018, in a private transaction,
we issued 1,666,669 shares of our common stock for gross proceeds of $9,000,000. In connection with this transaction, we incurred
equity issuance costs of $835,526 related to payments to advisors and legal fees associated with the transaction, resulting in
net proceeds to the Company of $8,164,474.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the quarters ended September 30, 2019, June 30, 2019,
and March 31, 2019, we issued 48,775, 60,295 and 89,826 shares, respectively, of our common stock and received proceeds of $206,324,
$214,314, and $343,785, respectively, in connection with the exercise of stock options under our 2013 equity compensation plan.
We issued an additional 12,052 shares of our common stock in the quarter ended March 31, 2019 in connection with the exercise of
options using the net-settled method, whereby no cash was received, but rather the exercise price was paid by the surrender of
shares underlying the options. We also issued 130,001 shares of our common stock in the quarter ended March 31, 2019 in connection
with restricted stock awards awarded in 2018. We issued 141,403 and 2,002 shares of our common stock and received proceeds of $451,022
and $4,920 in connection with the exercise of options in the quarters ended September 30, 2018 and June 30, 2018, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Director Compensation Plan calls for issuance of 2,084 shares
per quarter to each independent director. In 2019, we issued 8,336 shares each quarter, valued at $106,034, $135,043, and $120,705
for the quarters ended March 31, June 30, and September 30, respectively. In 2018, we issued 6,249 shares valued at $28,875, 8,336
shares valued at $89,945, and 11,489 shares valued at $206,082 for the quarters ended March 31, June 30, and September 30, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective May 14, 2018, in connection with our listing on the
Nasdaq Capital Market, we implemented a reverse split of our common stock by exchanging each three shares of our common stock for
one share. The effect of this reverse split is presented in the accompanying condensed consolidated financial statements as if
it had been effective as of the beginning of the earliest period presented. We elected to round fractional shares up to the nearest
whole number rather than redeem them for cash, and as a result we issued 908 additional shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the quarter ended March 31, 2018, we issued 100,000 shares
of common stock to a subsidiary of WPP, plc, a shareholder at the time, in full payment of all amounts due under a co-marketing
agreement that covered certain WPP, plc agencies, whereby we shared a portion of our revenue with those agencies related to programs
awarded to us by those agencies. The shares were valued at $447,000, the market value of the stock on the date of issuance. The
amount due was recorded as a liability in revenue share payable at December 31, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the quarter ended September 30, 2018, we issued 10,000 shares
valued at $148,050 in connection with investor relations services.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 4 – STOCK BASED COMPENSATION</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We use the fair value method to account for stock-based compensation.
We recorded $1,329,713 and $878,768 in compensation expense in the nine months ended September 30, 2019 and 2018, respectively,
related to options issued under our stock-based incentive compensation plan. This includes expense related to options issued in
prior years for which the requisite service period for those options includes the current period as well as options issued in the
current period. The fair value of these instruments was calculated using the Black-Scholes option pricing model. There is $1,462,423
of remaining expense related to unvested options to be recognized in the future over a weighted average remaining period of less
than one year. The total intrinsic value of outstanding options at September 30, 2019 is $13,318,970.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The company also recorded expense related to restricted stock
awards of $78,225 and $364,008 for the nine months ended September 30, 2019 and 2018, respectively. As of September 30, 2019, there
is $1,513,475 of remaining expense related to unvested restricted stock awards to be recognized in the future related to 140,000
shares of restricted stock awards that are unvested at September 30, 2019.</p>
13318970
1462423
1513475
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 5 – CONTINGENCIES</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Litigation</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is not currently involved in any legal proceedings.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 6 – (LOSS) EARNINGS PER SHARE</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the computation of basic and
diluted (loss) earnings per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"> </p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended <br /> September 30,</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br /> September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Numerator</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 52%; text-align: left; padding-bottom: 4pt; padding-left: 10pt">Net (loss) income</td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(1,570,942</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">244,928</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(1,157,796</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">336,258</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Denominator</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -10pt; padding-left: 10pt">Weighted average shares outstanding used in computing (loss) earnings per share</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Basic</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">14,146,489</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">11,755,500</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,996,590</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,840,584</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 20pt">Effect of dilutive stock options, warrants, and unvested restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166,268</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">936,170</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Diluted</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">14,146,489</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,921,768</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,996,590</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">11,776,754</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> (Loss) earnings per share</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Basic</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.11</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.02</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.09</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.03</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Diluted</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.11</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.02</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.09</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.03</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No calculation of diluted earnings per share is included for
2019 as the effect of the calculation would be antidilutive.</p>
-1157796
336258
-1570942
244928
12996590
10840584
14146489
11755500
936170
1166268
12996590
11766754
14146489
12921768
-0.09
0.03
-0.11
0.02
-0.09
0.03
-0.11
0.02
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 7 – SUBSEQUENT EVENTS</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2019, we completed the acquisition of 100% of the
outstanding shares of RMDY Health, Inc., a privately held leading provider of collaborative digital therapeutics SaaS solutions
for the healthcare industry. This strategic acquisition allows us to extend our ability to engage doctors and patients for our
pharmaceutical clients, introduce important client segments to our solution site, and continue expanding on our patient engagement
revenue stream. The purchase price was $16.0 million, which will be adjusted for final working capital acquired. Total cash paid
in October as part of the transaction was $8.7 million, which included payments for closing indebtedness, transaction expenses,
escrows, and payments to RMDY Health stockholders. There were approximately $300,000 of costs directly related to the acquisition
included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2019 as well.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, a portion of the purchase price, $5.9 million,
is payable in shares of our common stock, and 382,893 shares will be issued in November 2019 in connection with this acquisition.
Additional shares may be issued in future years at the time of the escrow release. Two additional payments not to exceed $30.0
million may become due as part of an earnout in the amount of 1.75 times the amount that we exceed $4.0 million of revenues related
to the "RMDY" product in 2020, and 1.75 times the amount that we exceed 2020 revenues related to the "RMDY"
product in 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since the acquisition occurred subsequent to September 30, 2019,
no results from operations of RMDY Health are included in our consolidated statement of operations for the three and nine months
ended September 30, 2019. It is currently impractical to disclose a preliminary purchase price allocation of RMDY Health or pro
forma financial information combining both companies as of the earliest period presented in these financial statements as RMDY
Health is currently in the process of both closing its books and records and converting them to U.S. GAAP.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the foregoing, all required financial information
concerning the RMDY Health acquisition will be included in an amended 8K with a due date of December 19, 2019.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with ASC 855-10, we have analyzed events and transactions
that occurred subsequent to September 30, 2019 through the date these financial statements were issued and have determined that
other than as discussed above, we do not have any material subsequent events to disclose or recognize in these financial statements.</p>
1.00
16000000
5900000
8700000
Two additional payments not to exceed $30.0 million may become due as part of an earnout in the amount of 1.75 times the amount that we exceed $4.0 million of revenues related to the "RMDY" product in 2020, and 1.75 times the amount that we exceed 2020 revenues related to the "RMDY" product in 2021.
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended <br /> September 30,</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br /> September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Numerator</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 52%; text-align: left; padding-bottom: 4pt; padding-left: 10pt">Net (loss) income</td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(1,570,942</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">244,928</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(1,157,796</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td>
<td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">336,258</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Denominator</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -10pt; padding-left: 10pt">Weighted average shares outstanding used in computing (loss) earnings per share</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Basic</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">14,146,489</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">11,755,500</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,996,590</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,840,584</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 20pt">Effect of dilutive stock options, warrants, and unvested restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166,268</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">936,170</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Diluted</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">14,146,489</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,921,768</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,996,590</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">11,776,754</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> (Loss) earnings per share</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Basic</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.11</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.02</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.09</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.03</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 4pt; padding-left: 20pt">Diluted</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.11</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.02</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.09</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td>
<td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.03</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr>
</table>
0.001
0.001
10000000
10000000
0.001
0.001
500000000
500000000
14173850
12038618
9772694
12038618
9878943
12278833
14173850
11556858
11970976
14116739
-142027
-3229
-142027
-3229
6
28869
8
106026
120705
354847
28875
8
22
120697
354825
106034
8
89937
89945
8
135035
135043
6249
8336
8336
21489
8336
8336
468247
530312
469539
353511
468247
469539
353311
530312
426755
426755
408087
408087
100
446900
447000
-189179
6529
-1570942
244928
-189179
-1570942
244928
6529
280509
280509
406617
406617
1
-1
908
102
343683
206324
451022
49
141
206275
450881
343785
2
4918
4920
61
214253
214314
101878
48775
141403
2002
60295
251046
130
-130
130001
745928
163418
1407938
1242776
-361782
-479203
-25000
700549
1734128
469623
-54108
184464
-291831
240329
414722
-772953
-139417
505279
164129
-160859
-140206
61457
23131
1000000
56651
-1061457
-79782
22369960
9455943
301711
835526
22068249
8620417
20845933
8400429
500000
3229
672809
447000
251
-251
300000
300000
Short-term lease cost includes any lease with a term of less than 12 months.
For the remaining three-month period beginning October 1, 2019.